#2319 - Rick Doblin
May 09, 2025•2 hr 19 min•Ep. 2319
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Summary
Rick Doblin discusses psychedelic therapy, its challenges, and potential benefits. He shares personal anecdotes, research insights, and the political landscape surrounding legalization efforts. The conversation covers MDMA-assisted therapy for PTSD, harm reduction strategies, and the importance of community and integration in psychedelic experiences, highlighting the long journey and future possibilities.Episode description
Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit Corporation) which is leading drug development of MDMA-assisted therapy for PTSD.
Learn more about Psychedelic Science 2025, June 16–20 at the Colorado Convention Center in Denver, at www.psychedelicscience.org, and visit www.maps.org for information on MAPS
Learn more about your ad choices. Visit podcastchoices.com/adchoices
For the best experience, listen in Metacast app for iOS or Android